X4 Pharmaceuticals, Inc. (XFOR)

4.48 +0.36 (+8.74%) USD  |  NASDAQ  |  Dec 24, 11:20
More

X4 Pharmaceuticals SG&A Expense (TTM): 51.28M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for XFOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Altimmune, Inc. 22.68M
Adverum Biotechnologies, Inc. 59.84M
Recursion Pharmaceuticals, Inc. 220.12M
Quantum-Si, Inc. 48.78M